AAAAAA
Results:
1-13
|
Results: 13
Authors:
Desai, HD
Seabolt, J
Jann, MW
Citation: Hd. Desai et al., Smoking in patients receiving psychotropic medications - A pharmacokineticperspective, CNS DRUGS, 15(6), 2001, pp. 469-494
Authors:
Jann, MW
Chang, WH
Lane, HY
Citation: Mw. Jann et al., Differences in haloperidol epidemiologic pharmacokinetic studies, J CL PSYCH, 21(6), 2001, pp. 628-630
Authors:
Lane, HY
Jann, MW
Chang, YC
Chiu, CC
Huang, MC
Lee, SH
Chang, WH
Citation: Hy. Lane et al., Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability, J CLIN PSY, 62(10), 2001, pp. 812-817
Authors:
Penzak, SR
Jann, MW
Cold, JA
Hon, YY
Desai, HD
Gurley, BJ
Citation: Sr. Penzak et al., Seville (sour) orange juice: Synephrine content and cardiovascular effectsin normotensive adults, J CLIN PHAR, 41(10), 2001, pp. 1059-1063
Authors:
Vandenberg, CM
Kazmi, Y
Jann, MW
Citation: Cm. Vandenberg et al., Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly, DRUG AGING, 16(2), 2000, pp. 123-138
Authors:
VanDenBerg, CM
Kazmi, Y
Stewart, J
Weidler, DJ
Tenjarla, SN
Ward, ES
Jann, MW
Citation: Cm. Vandenberg et al., Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion, AM J HEAL S, 57(11), 2000, pp. 1046-1050
Authors:
Lane, HY
Liu, HC
VandenBerg, CM
Su, MH
Jann, MW
Chang, WH
Citation: Hy. Lane et al., Disposition of olanzapine in Chinese schizophrenic patients, INT J CL PH, 38(10), 2000, pp. 482-485
Authors:
Jann, MW
Citation: Mw. Jann, Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease, PHARMACOTHE, 20(1), 2000, pp. 1-12
Authors:
Aitchison, KJ
Jann, MW
Zhao, JH
Sakai, T
Zaher, H
Wolff, K
Collier, DA
Kerwin, RW
Gonzalez, FJ
Citation: Kj. Aitchison et al., Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice, J PSYCHOPH, 14(4), 2000, pp. 353-359
Authors:
Chang, WH
Augustin, B
Lane, HY
ZumBrunnen, T
Liu, HC
Kazmi, Y
Jann, MW
Citation: Wh. Chang et al., In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine, PSYCHOPHAR, 145(1), 1999, pp. 91-98
Authors:
Penzak, SR
Grimsley, SR
Jann, MW
Citation: Sr. Penzak et al., Significant interactions with new antiretrovirals and psychotropic drugs -Comment, ANN PHARMAC, 33(12), 1999, pp. 1372-1373
Authors:
Lane, HY
Chang, YC
Chang, WH
Lin, SK
Tseng, YT
Jann, MW
Citation: Hy. Lane et al., Effects of gender and age on plasma levels of clozapine and its metabolites: Analyzed by critical statistics, J CLIN PSY, 60(1), 1999, pp. 36
Authors:
Jann, MW
Cyrus, PA
Eisner, LS
Margolin, DI
Griffin, T
Gulanski, B
Citation: Mw. Jann et al., Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial, CLIN THER, 21(1), 1999, pp. 88-102
Risultati:
1-13
|